MDxHealth S.A. logo

MDxHealth S.A.

MDXH | NASDAQ
Chart Builder DCF Calculator
$0.60
$0 (0.00%)
At close: Sep 22, 2026, 4:00 PM ET
$0.64
+$0.04 (+6.82%)
After-hours: Sep 22, 2026, 7:35 PM ET

Market Data

Market Cap
$30.82M
Enterprise Value
$117.46M
Beta
0.38
Average Volume
4.52M
Shares Outstanding (Diluted)
52.42M
Shares Change YoY
92.09%
Institutional Ownership
49.46%
Exchange
NASDAQ
ISIN
BE0974461940

Price Performance

Price Change 1M
-20.0%
Price Change 3M
16.5%
Price Change 6M
-79.0%
Price Change YTD
-82.5%
Price Change 1Y
-87.2%
Price Change 3Y
-78.0%
Price Change 5Y
-95.0%
1M CAGR (ann.)
30.1%
1Y CAGR (ann.)
-84.6%
5Y CAGR (ann.)
N/A
All-Time CAGR
-45.9%

Valuation

PE Ratio
-1.02
Forward PE
121.00
PEG Ratio
-0.03
Forward PEG
0.02
PS Ratio
0.38
Forward PS
0.20
PB Ratio
-1.01
P/FCF Ratio
-5.54
P/Adj. FCF Ratio
-6.41
P/OCF Ratio
-6.00
EV/Sales
1.43
EV/EBIT
-7.93
EV/EBITDA
-15.16
EV/FCF
-21.11
Earnings Yield
-98.3%
FCF Yield
-18.1%
Adj. FCF Yield
-15.6%

Financial Health

Net Debt
$77.2M
Total Debt
$105.85M
Cash & Short-Term Investments
$19.21M
Total Assets
$132.09M
Current Ratio
1.15
Quick Ratio
0.98
Debt / Equity Ratio
-3.48
Debt / EBITDA
-13.66
Debt / FCF
-19.03
OCF / Debt
-0.05
Interest Coverage
-1.15
Altman Z-Score
-4.07
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
57.6%
Operating Profit Margin
-20.4%
EBITDA Margin
-9.5%
Net Profit Margin
-37.0%
FCF Margin
-6.8%
Adj. FCF Margin
-5.9%
SBC / Revenue
-0.9%
SBC Impact (per share)
-13.6%

Returns

Return on Assets
-22.9%
Return on Equity
142.6%
Return on Invested Capital
-16.7%
Return on Capital Employed
-17.6%
Return on Tangible Assets
-54.0%

Historical Growth (CAGR)

Revenue CAGR 3Y
96.5%
Revenue CAGR 5Y
29.2%
Revenue CAGR 10Y
40.5%
EPS CAGR 3Y
68.1%
EPS CAGR 5Y
43.0%
EPS CAGR 10Y
15.3%
FCF CAGR 3Y
57.6%
FCF CAGR 5Y
6.6%
FCF CAGR 10Y
-4.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
6
EPS Growth Next 3Y
33.9%
Revenue Growth Next 3Y
25.9%
Earnings Date
Aug 12, 2026
EPS Estimate (next Q)
-$0.19
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
$26.14M
Revenue Growth Est (next Q)
-1.7%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$2.50
Price Target Upside
316.7%

Cash Flow

Operating Cash Flow
$-5.47M
Free Cash Flow
$-5.56M
Adj. Free Cash Flow
$-4.81M
FCF Per Share
-$0.11
OCF Per Share
-$0.10
OCF/S Ratio
-6.7%

Income Statement

Revenue
$81.87M
Gross Profit
$47.2M
Operating Income
$-16.67M
EBITDA
$-7.75M
Net Income
$-30.31M
EPS (Diluted)
-$0.59
Revenue / Employee
$224.93K
Profit / Employee
$-83.26K
Employees
364

© 2026 bestshares.com. All rights reserved.